Shearman & Sterling advised an investor consortium consisting of funds advised by ECM Equity Capital Management, PINOVA Capital and Gilde Healthcare Private Equity on the financing of the acquisition of a majority stake in DETAX Group, a leading supplier of polymer materials for medical applications, in connection with a management buy-out. The Investor Consortium and the management team aim to further promote growth by internationalization, digitalization and innovation.

DETAX, based in Ettlingen, Germany, was founded in 1953 and today employs approximately 110 people. As a specialist in polymer materials, the group offers its customers a comprehensive product portfolio of dental and otoplastic consumables. The group serves an international, broadly diversified and loyal customer base.

ECM is a trusted growth partner for mid-sized enterprises and entrepreneurs in the DACH region. The funds invest primarily in leading mid-market companies with attractive growth potential in the context of ownership successions, partnership transactions and corporate spin-offs.

PINOVA Capital is an independent private equity firm investing in high-growth technology companies in the DACH region. PINOVA Capital focuses on innovative mid-market companies.

Gilde Healthcare is a specialized healthcare investor with two fund strategies: Venture & Growth and Private Equity. Gilde targets healthcare providers, suppliers of medical products and service providers in the healthcare market.